OverviewSuggest Edit

Dare Bioscience (formerly Cerulean Pharma) is a clinical-stage oncology-focused company developing nanoparticle-drug conjugates, is committed to improving treatment for people living with cancer. The Company applies Dynamic Tumor Targeting Platform to create a growing portfolio of nanoparticle-drug conjugate designed to selectively attack tumor cells, reduce toxicity by sparing the body's normal cells, and enable therapeutic combinations.

TypePublic
Founded2006
HQSan Diego, CA, US
Websitedarebioscience.com

Latest Updates

Employees (est.) (Dec 2018)9(+80%)
Revenue (FY, 2016)$766 K(+858%)
Share Price (Sept 2021)$1.6(-1%)
Cybersecurity ratingAMore

Key People/Management at Dare Bioscience

Susan L. Kelley

Susan L. Kelley

Director
Jessica Grossman

Jessica Grossman

Director
Scott Eliasof

Scott Eliasof

Vice President, Research
William H. Rastetter

William H. Rastetter

Lead Independent Director, Chairman of the Board
Sabrina Martucci Johnson

Sabrina Martucci Johnson

President and Chief Executive Officer, Director
Oliver S. Fetzer

Oliver S. Fetzer

President and Chief Executive Officer
Show more

Dare Bioscience Office Locations

Dare Bioscience has an office in San Diego
San Diego, CA, US (HQ)
3655 Nobel Dr #260
Show all (1)

Dare Bioscience Financials and Metrics

Dare Bioscience Revenue

Dare Bioscience's revenue was reported to be $766 k in FY, 2016
USD

Net income (Q1, 2021)

(7.3m)

EBIT (Q1, 2021)

(7.7m)

Market capitalization (14-Sept-2021)

81.4m

Closing stock price (14-Sept-2021)

1.6

Cash (31-Mar-2021)

7.7m
Dare Bioscience's current market capitalization is $81.4 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

80.0k766.0k

General and administrative expense

8.6m11.2m10.4m2.7m4.7m5.3m6.5m

R&D expense

11.8m25.9m27.6m984.7k6.4m8.5m20.8m

Operating expense total

20.4m37.2m37.9m3.7m11.1m13.8m27.3m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q1, 2021

Revenue

47.0k33.0k1.2m642.0k

General and administrative expense

1.5m2.0m2.4m2.7m2.7m3.0m3.1m2.8m2.4m3.6m3.4m1.1m1.3m1.2m1.2m1.3m1.3m1.3m1.9m1.6m1.9m

R&D expense

1.5m2.6m2.9m5.0m6.7m7.1m9.8m7.5m7.1m4.7m1.3m280.8k1.1m2.2m1.4m1.7m2.5m2.0m2.4m5.5m5.7m

Operating expense total

3.0m4.7m5.4m7.7m9.4m10.0m12.9m10.3m9.5m8.2m4.7m1.3m2.4m3.4m2.6m3.0m4.0m3.3m4.2m7.1m7.7m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

51.2m75.9m35.0m7.6m6.8m4.8m4.7m

Accounts Receivable

284.2k31.0k555.2k460.2k

Prepaid Expenses

311.6k403.1k1.1m1.9m

Inventories

12.3m1.7m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q1, 2021

Cash

8.5m64.3m57.8m56.3m85.5m77.6m60.5m47.2m38.1m12.0m7.2m8.5m15.6m12.4m9.5m3.5m5.6m2.4m5.0m5.3m7.7m

Accounts Receivable

1.1m710.7k28.9k24.6k80.3k166.7k493.0k37.8k429.7k177.1k301.8k

Prepaid Expenses

987.0k1.1m290.9k347.4k549.9k588.5k438.0k770.5k3.8m2.3m1.6m

Current Assets

11.5m65.4m59.7m58.6m87.1m79.2m62.1m48.9m39.2m15.6m8.1m10.4m15.9m12.8m10.2m4.3m6.6m3.2m9.3m7.8m9.6m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(23.3m)(39.6m)(39.3m)(11.5m)(16.7m)(14.3m)(27.4m)

Depreciation and Amortization

126.0k192.0k261.0k2.4k11.1k43.2k

Inventories

(5.7m)38.5m

Accounts Payable

341.0k795.0k(603.0k)753.1k151.5k608.7k(61.8k)
USDQ1, 2014

Financial Leverage

-0.1 x
Show all financial metrics

Dare Bioscience Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Dare Bioscience Online and Social Media Presence

Embed Graph

Dare Bioscience Blogs

Daré Bioscience to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

SAN DIEGO , Sept. 08, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson , its President and Chief Executive Officer, will deliver a company presentation at the H.C.

Daré Bioscience to Present at 2021 BIO Digital

SAN DIEGO , June 04, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.   (NASDAQ: DARE), a leader in women’s health innovation, today announced that it has been selected to deliver a company presentation at 2021 BIO Digital, being held virtually June 10-11 and 14-18, 2021.

Daré Bioscience Completes Recruitment in Phase 1 Clinical Trial of DARE-HRT1, a Novel Intravaginal Ring Designed to Deliver Non-Oral, Bio-identical Hormone Therapy for the Treatment of Vasomotor Symptoms & Genitourinary Syndrome Associated with Menopause

Topline data readout anticipated in the second quarter 2021 SAN DIEGO , March 22, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a leader in women’s health innovation, today announced completion of patient recruitment in its Phase 1 clinical trial of DARE-HRT1 being conducted

Daré Bioscience to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference

Daré Bioscience to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference Content Import Tue, 01/05/2021 - 08:01 Daré Bioscience to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference 01-05-2021 at 8:00 AM ES…

Daré Bioscience to Host Third Quarter 2020 Financial Results and Company Update Conference Call and Webcast on November 12, 2020

Daré Bioscience to Host Third Quarter 2020 Financial Results and Company Update Conference Call and Webcast on November 12, 2020 Content Import Thu, 11/05/2020 - 08:01 Daré Bioscience to Host Third Quarter 2020 Financial Results and Company Update Conference Call and Webcast on November 12…

Dare Bioscience Frequently Asked Questions

  • When was Dare Bioscience founded?

    Dare Bioscience was founded in 2006.

  • Who are Dare Bioscience key executives?

    Dare Bioscience's key executives are Susan L. Kelley, Jessica Grossman and Scott Eliasof.

  • How many employees does Dare Bioscience have?

    Dare Bioscience has 9 employees.

  • Who are Dare Bioscience competitors?

    Competitors of Dare Bioscience include Greenwich LifeSciences, Nanospectra Biosciences and CNS Pharmaceuticals.

  • Where is Dare Bioscience headquarters?

    Dare Bioscience headquarters is located at 3655 Nobel Dr #260, San Diego.

  • Where are Dare Bioscience offices?

    Dare Bioscience has an office in San Diego.

  • How many offices does Dare Bioscience have?

    Dare Bioscience has 1 office.